Allena Pharmaceuticals, Inc. Gains 31.65%
Allena Pharmaceuticals, Inc. (ALNA:NASDAQ) rocketted at $0.16, representing a gain of 31.6%. On Wed, Jun 08, 2022, ALNA:NASDAQ hit a New 2-Week Intraday High of $0.13. From Wed, May 25, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Thu, May 12, 2022 at $0.21 with a volume of 250M+, and its share price has been moving sideways in recent weeks.
About Allena Pharmaceuticals, Inc. (ALNA:NASDAQ)
Allena Pharmaceuticals Inc is a clinical biopharmaceutical company. It focuses on developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.
Top 10 Gainers:
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 189.86%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 93.43%
- DBV Technologies S.A. (DBVT:NASDAQ), 79.56%
- Applied UV Inc. (AUVI:NASDAQ), 55.37%
- View Inc. (VIEW:NASDAQ), 47.98%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 35.54%
- Zynerba Pharmaceuticals, Inc. (ZYNE:NASDAQ), 35.09%
- Eros Media World PLC Ord Cl A (EMWP:NYSE), 32.81%
- Allena Pharmaceuticals, Inc. (ALNA:NASDAQ), 31.65%
- Digital Brands Group Inc. (DBGI:NASDAQ), 28.47%